786 related articles for article (PubMed ID: 29110848)
1. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
[TBL] [Abstract][Full Text] [Related]
6. Probability of cancer in pulmonary nodules detected on first screening CT.
McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
[TBL] [Abstract][Full Text] [Related]
7. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
8. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
[TBL] [Abstract][Full Text] [Related]
9. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Patient With a Pulmonary Nodule: A Review.
Mazzone PJ; Lam L
JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
[TBL] [Abstract][Full Text] [Related]
13. Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study.
Zhao YR; Heuvelmans MA; Dorrius MD; van Ooijen PM; Wang Y; de Bock GH; Oudkerk M; Vliegenthart R
Radiology; 2014 Mar; 270(3):872-9. PubMed ID: 24475806
[TBL] [Abstract][Full Text] [Related]
14. New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON Study.
Han D; Heuvelmans MA; van der Aalst CM; van Smoorenburg LH; Dorrius MD; Rook M; Nackaerts K; Walter JE; Groen HJM; Vliegenthart R; de Koning HJ; Oudkerk M
J Thorac Oncol; 2020 Jan; 15(1):125-129. PubMed ID: 31606605
[TBL] [Abstract][Full Text] [Related]
15. Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.
Heuvelmans MA; Walter JE; Vliegenthart R; van Ooijen PMA; De Bock GH; de Koning HJ; Oudkerk M
Thorax; 2018 Aug; 73(8):779-781. PubMed ID: 29056601
[TBL] [Abstract][Full Text] [Related]
16. Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial.
Xu DM; van Klaveren RJ; de Bock GH; Leusveld A; Zhao Y; Wang Y; Vliegenthart R; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
Eur J Radiol; 2008 Nov; 68(2):347-52. PubMed ID: 17920800
[TBL] [Abstract][Full Text] [Related]
17. Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT.
Venkadesh KV; Setio AAA; Schreuder A; Scholten ET; Chung K; W Wille MM; Saghir Z; van Ginneken B; Prokop M; Jacobs C
Radiology; 2021 Aug; 300(2):438-447. PubMed ID: 34003056
[TBL] [Abstract][Full Text] [Related]
18. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
Winter A; Aberle DR; Hsu W
Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
[TBL] [Abstract][Full Text] [Related]
19. Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.
Xu DM; van Klaveren RJ; de Bock GH; Leusveld AL; Dorrius MD; Zhao Y; Wang Y; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
Eur J Radiol; 2009 Jun; 70(3):492-8. PubMed ID: 18417311
[TBL] [Abstract][Full Text] [Related]
20. Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.
van Riel SJ; Ciompi F; Winkler Wille MM; Dirksen A; Lam S; Scholten ET; Rossi SE; Sverzellati N; Naqibullah M; Wittenberg R; Hovinga-de Boer MC; Snoeren M; Peters-Bax L; Mets O; Brink M; Prokop M; Schaefer-Prokop C; van Ginneken B
PLoS One; 2017; 12(11):e0185032. PubMed ID: 29121063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
